We are live on ! Find out more
Daiwa Securities Group

Daiwa Securities Group Portfolio holdings

AUM $34.8B
1-Year Est. Return 20.7%
This Fund
S&P 500
This Quarter Est. Return
+1.69%
1 Year Est. Return
+20.7%
3 Year Est. Return
+66.64%
5 Year Est. Return
+79.21%
10 Year Est. Return
+192.59%
AUM
$22.4B
AUM Growth
+$745M
Cap. Flow
+$687M
Cap. Flow %
3.07%
Top 10 Hldgs %
31.51%
Holding
1,352
New
72
Increased
666
Reduced
342
Closed
71

Top Buys

Rank Stock Value
1
AMT icon
American Tower
AMT
+$191M
2
MSFT icon
Microsoft
MSFT
+$116M
3
NVDA icon
NVIDIA
NVDA
+$115M
4
AAPL icon
Apple
AAPL
+$108M
5
WY icon
Weyerhaeuser
WY
+$83.8M

Top Sells

Rank Stock Value
1
IVV icon
iShares Core S&P 500 ETF
IVV
+$118M
2
DLR icon
Digital Realty Trust
DLR
+$106M
3
CCI icon
Crown Castle
CCI
+$104M
4
SPG icon
Simon Property Group
SPG
+$93M
5
KIM icon
Kimco Realty
KIM
+$64.5M

Sector Composition

Rank Sector Weight
1 Real Estate 37.54%
2 Technology 23.33%
3 Communication Services 8.01%
4 Consumer Discretionary 6.37%
5 Financials 5.98%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
AMLX icon
1226
Amylyx Pharmaceuticals
AMLX
$2.17B
$1K ﹤0.01%
266
– –
AMRN
1227
Amarin Corp
AMRN
$293M
$1K ﹤0.01%
67
– –
ANAB icon
1228
AnaptysBio
ANAB
$1.54B
$1K ﹤0.01%
105
– –
AURA icon
1229
Aura Biosciences
AURA
$729M
$1K ﹤0.01%
+165
New +$1.55K
AVIR icon
1230
Atea Pharmaceuticals
AVIR
$361M
$1K ﹤0.01%
242
– –
BCYC
1231
Bicycle Therapeutics
BCYC
$275M
$1K ﹤0.01%
103
– –
CDXS icon
1232
Codexis
CDXS
$136M
$1K ﹤0.01%
+269
New +$1.11K
EYPT icon
1233
EyePoint Inc
EYPT
$1B
$1K ﹤0.01%
144
– –
LKFT
1234
Lakefront Biotherapeutics American Depositary Shares
LKFT
$1.84B
$1K ﹤0.01%
51
– –
GLUE icon
1235
Monte Rosa Therapeutics
GLUE
$1.86B
$1K ﹤0.01%
+203
New +$1.52K
HCM icon
1236
HUTCHMED
HCM
$1.93B
$1K ﹤0.01%
85
– –
ITOS
1237
DELISTED
iTeos Therapeutics
ITOS
$1K ﹤0.01%
121
– –
KALV
1238
DELISTED
KalVista Pharmaceuticals
KALV
$1K ﹤0.01%
154
– –
LXRX icon
1239
Lexicon Pharmaceuticals
LXRX
$1.04B
$1K ﹤0.01%
1,369
– –
LYEL icon
1240
Lyell Immunopharma
LYEL
$318M
$1K ﹤0.01%
46
– –
MGNX icon
1241
MacroGenics
MGNX
$245M
$1K ﹤0.01%
209
– –
MGTX icon
1242
MeiraGTx Holdings
MGTX
$1.09B
$1K ﹤0.01%
130
– –
MXCT icon
1243
MaxCyte
MXCT
$112M
$1K ﹤0.01%
293
– –
OLMA icon
1244
Olema Pharmaceuticals
OLMA
$1.01B
$1K ﹤0.01%
224
– –
PAHC icon
1245
Phibro Animal Health
PAHC
$1.48B
$1K ﹤0.01%
38
– –
PGEN icon
1246
Precigen
PGEN
$1.97B
$1K ﹤0.01%
708
– –
PRME icon
1247
Prime Medicine
PRME
$558M
$1K ﹤0.01%
398
– –
RGNX icon
1248
Regenxbio
RGNX
$615M
$1K ﹤0.01%
146
– –
SAGE
1249
DELISTED
Sage Therapeutics
SAGE
$1K ﹤0.01%
239
– –
SANA icon
1250
Sana Biotechnology
SANA
$916M
$1K ﹤0.01%
767
– –
48 49
50
51 52

Similar funds

SAM
Storebrand Asset Management Lysaker, Norway $34.8B AUM 25.49% 1-Year Est. Return
Chevy Chase Trust
Chevy Chase Trust Bethesda, Maryland $34.7B AUM 29.45% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return
VIA
Vanguard Investments Australia Victoria, Australia $34.6B AUM
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
Parnassus Investments
Parnassus Investments San Francisco, California $34.1B AUM 20.22% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return
Pacer Advisors
Pacer Advisors Malvern, Pennsylvania $35.6B AUM 18.19% 1-Year Est. Return

Daiwa Securities Group's Q4 2024 Portfolio in Review

As of Q4 2024, Daiwa Securities Group held 1,352 positions worth $22.4B, up 3.4% from $21.6B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Daiwa Securities Group deployed $687M of net new capital in Q4 2024, opening 72 new positions and adding to 666 existing holdings. Its largest new stake was Curbline Properties: 2,033,334 shares worth $47.2M.

By sector, the portfolio is most concentrated in Real Estate at 38% of assets, down from 42% a quarter earlier, followed by Technology and Communication Services.

On the sell side, the largest reduction was iShares Core S&P 500 ETF, an estimated $118M trimmed.

  • Daiwa Securities Group's largest Q4 2024 buy was Curbline Properties: 2,033,334 shares worth $47.2M.
  • Daiwa Securities Group added most to American Tower in Q4 2024, an estimated $191M increase.
  • Daiwa Securities Group's biggest Q4 2024 reduction was iShares Core S&P 500 ETF, cutting an estimated $118M.
  • Daiwa Securities Group fully exited State Street SPDR S&P 500 ETF Trust in Q4 2024, selling an estimated $10.3M.
  • Daiwa Securities Group's ten largest holdings make up 32% of its $22.4B portfolio in Q4 2024.
  • Daiwa Securities Group opened 72 new positions and closed 71 in Q4 2024.
  • Daiwa Securities Group's portfolio value rose 3.4% quarter-over-quarter to $22.4B.

Based on Daiwa Securities Group's 13F filing for Q4 2024, filed 7 Feb 2025.